Skip to content
Recall Observatory FDA recall evidence

Drug product

Prempro (Conjugated Estrogen/Medroxyprogesterone Acetate) tablets 0.625 mg/5.0 mg, 1 blister card containing 28 tablets, Rx only, Wyeth Pharmaceuticals Inc., Philadelphia, PA 1910, NDC 0046-0975-11

D-631-2013

May 31, 2013

Class III

Product summary

Firm
Pfizer Inc.
Event
Event 65393
Status
Terminated
Classification
Class III
Quantity
135,520 blister cards
Official record key
drug-enforcement:D-631-2013

Official wording

Reason: Failed Dissolution Specifications: Pfizer Inc. (Pfizer) is recalling PREMPRO (conjugated estrogens/medroxyprogesterone acetate tablets) because certain lots for this product may not meet the specification for conjugated estrogens dissolution.

Code information: Lots: E77055, E96153, & F11111 Exp: 06/13

Distribution pattern: Nationwide and Puerto Rico

Derived failure modes

  • Potency or specification failure

    reason.potency_specification_failure · v1.0.0

    Failed Dissolution Specifications